Value proposition

Together, we can make a lasting impact on global health – and your business.

We’re Rabin Martin, a team of global health impact consultants. Driving better outcomes, access and equity – from strategy to execution. ​

We design, develop and deliver effective solutions to unlock new markets and opportunities – creating creative ways for more people to access our client's medicines and vaccines, and generating support among key stakeholders. ​

In today’s competitive and complex healthcare environment, leveraging Global Health expertise and partnerships, from strategy to execution, is a must-have in unlocking incremental growth. To do this, we bring together unrivaled global health and equity expertise – with decades of experience in commercial strategy, health system strengthening, health equity, and therapeutic area expertise – from cancer and chronic disease to rare diseases and maternal and child health. And we’re trained to see connections and know how to leverage local market knowledge, policy and partnerships to have a bigger impact on business and public health outcomes. ​

​It's why we've worked with the leading players in health, from entities within the UN, to pharma leaders like J&J and Takeda, to the Rockefeller and Bill & Melinda Gates Foundations. And have managed more than $2 billion in health and equity programming – across 80 markets including US, Europe and Low-to-Middle Income Countries. ​

But a global health strategy that sits on a shelf doesn’t make an impact – on your business or the people who can’t access your medicines today. So, we follow it through to make a lasting impact. And we make it real by working side-by-side with you – managing everything from strategy and solution development to implementation, measurement, and evaluation. ​

Do more for society. Deliver more for business. ​

Questions? info@rabinmartin.com

Strategy consulting, program design and implementation, partnership management, policy and advocacy, corporate responsibility, reputation management, Executive platforms, Commercial strategy, Signature ESG inititives, Financing models, Digital health, Health equity, Social determinants of health, Patient engagement, and Monitoring, measurement and evalution